Neuland Laboratories Share Price

Neuland Labs.

CMP as on 18-May-22 15:29

₹ 1,060.00
24.90 2.41%

Open

₹ 1,044.00

Turnover (lac)

₹ 198

Prev. Close

₹ 1,035.10

Day's Vol (shares)

₹ 18,700

Day's Range (₹)

₹ 1,039.95
₹ 1,060.00

CMP as on18-May-22 15:28

₹ 1,059.00
24.8 2.4%

Open

₹ 1,050.00

Turnover (lac)

₹ 60

Prev. Close

₹ 1,034.20

Day's Vol (shares)

₹ 1,738

Day's Range

₹ 1,043.60
₹ 1,059.25

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 18-Apr-2022 - -
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2022 inter alia to consider and approve the Audited Financial Results for the quarter and year ended March 31 2022 and to recommend final dividend for FY 2021-22 If any Neuland Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 10, 2022, inter alia, have recommended payment of final dividend of Rs. 5.00/- (50%) per equity share on a face value of Rs.10 each, subject to the approval of members of the Company. Outcome of Board Meeting, Audited results and recommendation of final dividend, for the year ended March 31, 2022 (As Per BSE Announcement Dated on 10.05.2022)
Board Meeting - 07-Jan-2022 - -
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2022 inter alia to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31 2021 Earnings Call Details for Q3 FY 2021-2022 scheduled to be held on February 1, 2022 at 17.30 hours, enclosed. (As Per BSE Announcement Dated on 28.01.2022) Unaudited Financial Results for the Quarter and nine months ended December 31, 2021 along with Press Release and Investor Presentation (As Per BSE Announcement dated on 01.02.2022)
Board Meeting - 20-Oct-2021 - -
Quarterly Results Unaudited Financial Results for the quarter and half year ended September 30, 2021 along with Press Release and Investor Presentation (As Per BSE Announcement dated on 29.10.2021)
Board Meeting - 16-Jul-2021 - -
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2021 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2021. Unaudited Financial Results For June 30, 2021 along with Press Release and Investor Presentation (As Per BSE Announcement dated on 03.08.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity